Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Quantity and quality of mental activities and the risk of incident mild cognitive impairment.

Krell-Roesch J, Syrjanen JA, Vassilaki M, Machulda MM, Mielke MM, Knopman DS, Kremers WK, Petersen RC, Geda YE.

Neurology. 2019 Aug 6;93(6):e548-e558. doi: 10.1212/WNL.0000000000007897. Epub 2019 Jul 10.

PMID:
31292224
2.

Comparison of the Short Test of Mental Status and the Montreal Cognitive Assessment Across the Cognitive Spectrum.

Townley RA, Syrjanen JA, Botha H, Kremers WK, Aakre JA, Fields JA, Machulda MM, Graff-Radford J, Savica R, Jones DT, Knopman DS, Petersen RC, Boeve BF.

Mayo Clin Proc. 2019 Aug;94(8):1516-1523. doi: 10.1016/j.mayocp.2019.01.043. Epub 2019 Jul 4.

PMID:
31280871
3.

Plasma and CSF neurofilament light: Relation to longitudinal neuroimaging and cognitive measures.

Mielke MM, Syrjanen JA, Blennow K, Zetterberg H, Vemuri P, Skoog I, Machulda MM, Kremers WK, Knopman DS, Jack C Jr, Petersen RC, Kern S.

Neurology. 2019 Jul 16;93(3):e252-e260. doi: 10.1212/WNL.0000000000007767. Epub 2019 Jun 10.

4.

Cortical β-amyloid burden, neuropsychiatric symptoms, and cognitive status: the Mayo Clinic Study of Aging.

Krell-Roesch J, Vassilaki M, Mielke MM, Kremers WK, Lowe VJ, Vemuri P, Machulda MM, Christianson TJ, Syrjanen JA, Stokin GB, Butler LM, Traber M, Jack CR Jr, Knopman DS, Roberts RO, Petersen RC, Geda YE.

Transl Psychiatry. 2019 Mar 28;9(1):123. doi: 10.1038/s41398-019-0456-z.

5.

Factors Associated With Meningioma Detected in a Population-Based Sample.

Cerhan JH, Butts AM, Syrjanen JA, Aakre JA, Brown PD, Petersen RC, Jack CR Jr, Roberts RO.

Mayo Clin Proc. 2019 Feb;94(2):254-261. doi: 10.1016/j.mayocp.2018.07.026.

PMID:
30711123
6.

Association of Cerebrospinal Fluid Neurofilament Light Protein With Risk of Mild Cognitive Impairment Among Individuals Without Cognitive Impairment.

Kern S, Syrjanen JA, Blennow K, Zetterberg H, Skoog I, Waern M, Hagen CE, van Harten AC, Knopman DS, Jack CR Jr, Petersen RC, Mielke MM.

JAMA Neurol. 2019 Feb 1;76(2):187-193. doi: 10.1001/jamaneurol.2018.3459.

PMID:
30419087
7.

Functional Activity and Neuropsychiatric Symptoms in Normal Aging and Mild Cognitive Impairment: The Mayo Clinic Study of Aging.

Krell-Roesch J, Cerhan LP, Machulda MM, Roberts RO, Mielke MM, Knopman DS, Syrjanen JA, Christianson TJ, Petersen RC, Geda YE.

Alzheimer Dis Assoc Disord. 2019 Jan-Mar;33(1):68-71. doi: 10.1097/WAD.0000000000000266. No abstract available.

PMID:
30106755
8.

Mediterranean Diet, Its Components, and Amyloid Imaging Biomarkers.

Vassilaki M, Aakre JA, Syrjanen JA, Mielke MM, Geda YE, Kremers WK, Machulda MM, Alhurani RE, Staubo SC, Knopman DS, Petersen RC, Lowe VJ, Jack CR, Roberts RO.

J Alzheimers Dis. 2018;64(1):281-290. doi: 10.3233/JAD-171121.

9.

In vivo 18F-AV-1451 tau PET signal in MAPT mutation carriers varies by expected tau isoforms.

Jones DT, Knopman DS, Graff-Radford J, Syrjanen JA, Senjem ML, Schwarz CG, Dheel C, Wszolek Z, Rademakers R, Kantarci K, Petersen RC, Jack CR Jr, Lowe VJ, Boeve BF.

Neurology. 2018 Mar 13;90(11):e947-e954. doi: 10.1212/WNL.0000000000005117. Epub 2018 Feb 9.

10.

Weighting and standardization of frequencies to determine prevalence of AD imaging biomarkers.

Roberts RO, Knopman DS, Syrjanen JA, Aakre JA, Vassilaki M, Kremers WK, Mielke MM, Machulda MM, Graff-Radford J, Geda YE, Vemuri P, Lowe V, Jack CR Jr, Petersen RC.

Neurology. 2017 Nov 14;89(20):2039-2048. doi: 10.1212/WNL.0000000000004652. Epub 2017 Oct 13.

11.

Mediterranean diet, micronutrients and macronutrients, and MRI measures of cortical thickness.

Staubo SC, Aakre JA, Vemuri P, Syrjanen JA, Mielke MM, Geda YE, Kremers WK, Machulda MM, Knopman DS, Petersen RC, Jack CR Jr, Roberts RO.

Alzheimers Dement. 2017 Feb;13(2):168-177. doi: 10.1016/j.jalz.2016.06.2359. Epub 2016 Jul 25.

Supplemental Content

Loading ...
Support Center